David Kirn, MD’s Post

Will you be at #dtxeurope next week? Alex Therapeutics founder and CEO John Drakenberg is speaking on a panel about staying pragmatic, positive and building sustainably. We believe there are lots of great opportunities for innovation and growth, despite some recent industry challenges. Reach out if you are attending and want to meet John for a chat! #dtxeurope #alextherapeutics

It's almost time. Register now for the webinar. Start Time is 11am ET/4pm BST! Get yourself a drink and join us for what will be great event and discussion today. #fierce #webinar #invivo #preclinical #data #climb #researchanddevelopment #discovery #drugdiscovery

Get excited for this webinar!!! Discussing how to make science better and accelerating the R&D process through digital technologies. Making the most of in vivo data!!!

Diving Deeper: Unveiling the Power of the Amplitude-Evotec Partnership! Building upon our recent announcement, let's take a closer look at how the Amplitude Ventures and Evotec partnership is poised to reshape the landscape of precision medicine. Amplitude's venture creation prowess, combined with Evotec's industrialized drug discovery platforms, is a formidable force. Together, we're accelerating the identification and validation of cutting-edge science, paving the way for the rapid formation of innovative companies. Through this partnership, Evotec gains co-investment rights in new companies originating from Pre-Amp, strengthening our commitment to fostering groundbreaking therapeutic concepts. Thomas Hanke, EVP Head of Academic Partnerships at Evotec and Dr. Michael Mee, Managing Director at Pre-Amp, believe in the potential of this partnership to co-create high-potential therapeutic concepts. 🔬 🌎 We're excited about the first project being approved and advancing towards proof-of-concept, and there's much more in store! Stay with us on this journey as we continue to push the boundaries of healthcare innovation and transform the lives of patients.  #PrecisionMedicine #InnovationPartnership #HealthTech

Digital therapeutics - from funding to revenue generation HLTH #HLTH2023 Great panel David Benshoof Klein Alexander A. Morgan, MD PhD Santosh Shanbhag The time is now.. FDA draft guidance can create a massive shift. Investment climate pushes DTX companies to be the best, to focus on strong clinically meaningful value and shorter term revenues. Product readiness-DTC-Partnerships: Find the right mix.

🌐 The Lynx.MD team is heading to San Diego for DIA 2024. Drug discovery is a complex, lengthy process. DIA brings together the life sciences community to discuss innovations accelerating advancements, bringing therapies to care faster. Reach out to the Lynx.MD team, including Collin Labar, on LinkedIn to learn more about how our partners are using Lynx.MD’s rich structured and unstructured data sets to find insights addressing medical affairs and market access. See you at #DIA2024! 🌟 #Data #Research

Exciting News! Octane is thrilled to announce our newest Octane Preferred Advisor, Precision Life Science Partners! We have partnered with Precision, a renowned life science company with extensive operational expertise. Their practical advice and actionable guidance to innovators and investors are invaluable. This collaboration is set to pave the way for transformative advancements in the life science industry. We are excited to expand our offerings and support entrepreneurs in this field. Precision's team of executives brings true subject matter expertise, particularly in Orthopaedics, Spine, Neurotechnology, and Biologics. They understand that each technology and startup has unique needs, and offer flexible solutions. For more information about Precision Life Science Partners, please reach out to Drew Trivisonno at dtrivisonno@precisionlifescipartners.com. Octane Capital & Growth has curated a broad portfolio of best-in-class Preferred Advisors that deliver operational and consultative expertise to emerging companies to reach their milestones faster and achieve revenue goals more effectively and efficiently. To view them, call and learn more, visit here: https://bit.ly/3OnL5PA #OctanePartnership #LifeScienceInnovation #EntrepreneurSupport #OctanePreferredAdvisor

Want to learn more about the impact of the #TPP? Learn about the Target Product Profile as an instrument when discussing partnerships and collaboration opportunities. Join the program through the link below to learn more. #mycompany #jnjinnovation

Thoughtful review of challenges and solutions in biotech drug development. Take a look.

A nice concise overview from Chris Smyth